Key result
Obstructive sleep apnea is associated with an increased prevalence and severity of non-alcoholic fatty liver disease, and CPAP treatment may stabilize or slow NAFLD progression.
Why the study?
Obstructive sleep apnea may be linked with the pathogenesis and severity of non-alcoholic fatty liver disease, but the association and the efficacy of CPAP treatment required further study.
Is there an association between non-alcoholic fatty liver disease and obstructive sleep apnea, and does CPAP treatment affect NAFLD progression?
Is there an association between non-alcoholic fatty liver disease and obstructive sleep apnea, and does CPAP treatment affect NAFLD progression?
This review highlights a significant association between OSA and NAFLD severity, suggesting that systematic polysomnography and CPAP treatment may benefit NAFLD patients.
No takes yet. Share an insight, caveat, or question.
OSA evaluation merits consideration in NAFLD; leaves open whether CPAP alters progression in prospective trials.
Umbro et al. (2020) conducted a review in Non-alcoholic fatty liver disease and obstructive sleep apnea. Obstructive sleep apnea was evaluated on Association between NAFLD and OSA, and efficacy of CPAP treatment. Obstructive sleep apnea is associated with an increased prevalence and severity of non-alcoholic fatty liver disease, and CPAP treatment may stabilize or slow NAFLD progression.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: